Valneva Se Share Price Today
(NASDAQ: VALN)

Name: Valneva Se Share Price Today (NASDAQ: VALN) - Valneva Se Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Valneva Se share price is $7.14 & ₹620.96 as on 6 Mar 2025, 2.30 'hrs' IST

$7.14

▲

0.29

(4.31%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Valneva Se share price in Dollar and Rupees. Guide to invest in Valneva Se stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Valneva Se, along with analyst recommendations, forecasts, and comprehensive financials.

Valneva Se share price movements

Today's Low: $6.97
Today's High: $7.14
$7.14
2.38%
Downside
Day's Volatility :2.38%
Upside
0.0%
52 Weeks Low: $3.62
52 Weeks High: $9.50
$7.14
49.3%
Downside
52 Weeks Volatility :61.89%
Upside
24.84%

Valneva Se (VALN) Returns

Period	Valneva Se	Sector (Health Care)	Index (Russel 2000)
3 Months	73.16%	2.1%	0.0%
6 Months	-3.31%	-4.1%	0.0%
1 Year	3.01%	2.2%	0.0%
3 Years	-74.67%	11.8%	-11.6%

Valneva Se (VALN) Key Statistics

in dollars & INR

Previous Close	$6.84
Open	$6.97
Today's High	$7.14
Today's Low	$6.97
Market Capitalization	$563.1M
Today's Volume	$10.3K
52 Week High	$9.5
52 Week Low	$3.62
Revenue TTM	$158.5M
EBITDA	$-76.2M
Earnings Per Share (EPS)	$-0.13
Profit Margin	-4.68%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-3.96%

How to invest in Valneva Se Stock (VALN) from India?

It is very easy for Indian residents to invest directly in Valneva Se from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Valneva Se stock in both Indian Rupees (INR) and US Dollars (USD). Search for Valneva Se or VALN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Valneva Se or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Valneva Se shares which would translate to 0.122 fractional shares of Valneva Se as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Valneva Se, in just a few clicks!

Returns in Valneva Se (VALN) for Indian investors in Rupees

The Valneva Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Valneva Se investment value today

Current value as on today

₹1,12,493

Returns

₹12,493

(+12.49%)

Returns from Valneva Se Stock

₹7,530 (+7.53%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Valneva Se (VALN)

-33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Valneva Se Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Valneva Se

General American Investors Co Inc
0.44%
Wells Fargo & Co
0.30%
Citadel Advisors Llc
0.09%
Ironwood Investment Management LLC
0.03%
ABC arbitrage SA
0.02%

Analyst Recommendation on Valneva Se

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Valneva Se(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Valneva Se Stock (VALN)

What analysts predicted

Upside of 115.51%

Target:

$15.39

Current:

$7.14

Insights on Valneva Se Stock (Ticker Symbol: VALN)

Price Movement
In the last 3 months, VALN stock has moved up by 73.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 32.75M → 45.82M (in $), with an average increase of 15.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -24.93M → -9.23M (in $), with an average increase of 170.0% per quarter
VALN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 59.8%
VALN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.2%
Price to Sales
ForVALN every $1 of sales, investors are willing to pay $3.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

VALN Valneva Se Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$128.6M	↑ 7.35%
Net Income	$3.7M	↓ 128.43%
Net Profit Margin	2.89%	↑ 13.8%

	FY19	Y/Y Change
Revenue	$140.2M	↑ 11.64%
Net Income	$-1.9M	↓ 153.43%
Net Profit Margin	-1.38%	↓ 4.27%

	FY20	Y/Y Change
Revenue	$134.2M	↓ 12.58%
Net Income	$-78.3M	↑ 3592.26%
Net Profit Margin	-58.37%	↓ 56.99%

	FY21	Y/Y Change
Revenue	$393.5M	↑ 215.52%
Net Income	$-83.0M	↑ 14.03%
Net Profit Margin	-21.09%	↑ 37.28%

	FY22	Y/Y Change
Revenue	$382.4M	↑ 3.8%
Net Income	$-151.6M	↑ 95.14%
Net Profit Margin	-39.66%	↓ 18.57%

	FY23	Y/Y Change
Revenue	$167.7M	↓ 57.46%
Net Income	$-110.6M	↓ 29.21%
Net Profit Margin	-65.99%	↓ 26.33%

	Q2 FY23	Q/Q Change
Revenue	$43.6M	↑ 20.08%
Net Income	$-18.4M	↓ 6.66%
Net Profit Margin	-42.05%	↑ 12.05%

	Q3 FY23	Q/Q Change
Revenue	$40.6M	↓ 5.38%
Net Income	$-36.5M	↑ 102.29%
Net Profit Margin	-89.9%	↓ 47.85%

	Q4 FY23	Q/Q Change
Revenue	$45.7M	↑ 10.05%
Net Income	$-35.1M	↓ 6.04%
Net Profit Margin	-76.75%	↑ 13.15%

	Q1 FY24	Q/Q Change
Revenue	$35.6M	↓ 21.83%
Net Income	$64.0M	↓ 283.19%
Net Profit Margin	179.86%	↑ 256.61%

	Q2 FY24	Q/Q Change
Revenue	$41.0M	↑ 16.2%
Net Income	$-26.8M	↓ 142.32%
Net Profit Margin	-65.51%	↓ 245.37%

	Q3 FY24	Q/Q Change
Revenue	$45.8M	↑ 20.4%
Net Income	$-9.2M	↓ 62.96%
Net Profit Margin	-20.16%	↑ 45.35%

	FY18	Y/Y Change
Profit	$79.2M	↑ 17.35%

	FY19	Y/Y Change
Profit	$84.7M	↑ 9.52%

	FY20	Y/Y Change
Profit	$68.1M	↓ 26.51%

	FY21	Y/Y Change
Profit	$181.1M	↑ 185.91%

	FY22	Y/Y Change
Profit	$39.0M	↓ 76.98%

	FY23	Y/Y Change
Profit	$57.6M	↑ 43.34%

	Q2 FY23	Q/Q Change
Profit	$7.5M	↓ 47.21%

	Q3 FY23	Q/Q Change
Profit	$18.3M	↑ 148.64%

	Q4 FY23	Q/Q Change
Profit	$17.3M	↓ 7.4%

	Q1 FY24	Q/Q Change
Profit	$11.5M	↓ 33.1%

	Q2 FY24	Q/Q Change
Profit	$15.7M	↑ 37.75%

	Q3 FY24	Q/Q Change
Profit	$20.1M	↑ 38.06%

	FY18	Y/Y Change
Operating Cash Flow	$18.5M	↑ 27.1%
Investing Cash Flow	$-3.3M	↓ 28.15%
Financing Cash Flow	$35.2M	↓ 396.46%

	FY19	Y/Y Change
Operating Cash Flow	$6.1M	↓ 66.09%
Investing Cash Flow	$-11.9M	↑ 266.3%
Financing Cash Flow	$-8.6M	↓ 124.87%

	FY20	Y/Y Change
Operating Cash Flow	$167.5M	↑ 2391.19%
Investing Cash Flow	$-23.5M	↑ 81.0%
Financing Cash Flow	$26.4M	↓ 382.48%

	FY21	Y/Y Change
Operating Cash Flow	$86.9M	↓ 44.17%
Investing Cash Flow	$-105.3M	↑ 381.47%
Financing Cash Flow	$174.7M	↑ 610.69%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-44.6M	↑ 68.98%
Investing Cash Flow	$-3.3M	↑ 0.0%
Financing Cash Flow	$-6.1M	↑ 48.32%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-76.2M	↑ 73.7%
Investing Cash Flow	$2.5M	↓ 176.94%
Financing Cash Flow	$38.0M	↓ 729.2%

Valneva Se Technicals Summary

Sell

Neutral

Buy

Valneva Se is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Valneva Se (VALN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Valneva Se	21.93%	-3.31%	3.01%	-74.67%	-76.48%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Valneva Se	72.37	NA	NA	-0.08	-0.04	-0.11	NA	1.55
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Valneva Se	Buy	$563.1M	-76.48%	72.37	-4.68%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Valneva Se

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.

Organization	Valneva Se
Employees	676
CEO	Mr. Thomas Lingelbach
Industry	Healthcare

Management People of Valneva Se

Name	Title
Mr. Thomas Lingelbach	President, CEO & Director
Mr. Peter Buhler	Chief Financial Officer
Mr. Franck Grimaud MBA	Chief Business Officer
Dr. Juan-Carlos Jaramillo M.D.	Chief Medical Officer
Ms. Dipal Patel	Chief Commercial Officer
Mr. Vincent Dequenne	Chief Operating Officer
Dr. Hanneke Schuitemaker Ph.D.	Chief Scientific Officer
Mr. Joshua Drumm Ph.D.	Vice President of Investor Relations
Ms. Laetitia Bachelot-Fontaine	VP of Global Communications & European Investor Relations
Ms. Petra Pesendorfer	Chief People Officer

Important FAQs about investing in VALN Stock from India :

What is Valneva Se share price today?

Valneva Se share price today stands at $7.14, Open: $6.97 ; Previous Close: $6.84 ; High: $7.14 ; Low: $6.97 ; 52 Week High: $9.50 ; 52 Week Low: $3.62.

The stock opens at $6.97, after a previous close of $6.84. The stock reached a daily high of $7.14 and a low of $6.97, with a 52-week high of $9.50 and a 52-week low of $3.62.

Can Indians buy Valneva Se shares?

Yes, Indians can invest in the Valneva Se (VALN) from India.

With INDmoney, you can buy Valneva Se at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Valneva Se at zero transaction cost.

How can I buy Valneva Se shares from India?

It is very easy to buy Valneva Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Valneva Se (VALN) be purchased?

Yes, you can buy fractional shares of Valneva Se with INDmoney app.

What are the documents required to start investing in Valneva Se stocks?

To start investing in Valneva Se, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.